Cargando…

Donor acquired visceral leishmaniasis following liver transplantation

Patients who undergo solid organ transplantation are at risk of opportunistic infection associated with immunosuppression. We report a case of confirmed donor derived visceral leishmaniasis (VL), in a patient following liver transplantation causing fever and pancytopenia. The diagnosis was confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhaliwal, Amritpal, Chauhan, Abhishek, Aggarwal, Dinesh, Davda, Pretin, David, Miruna, Amel-Kashipaz, Rasoul, Brown, Rachel, Dedicoat, Martin, Clark, Fiona, Shah, Tahir, Elsharkawy, Ahmed Mohamed, Ushiro-Lumb, Ines, Chiodini, Peter, El-Sherif, Omar, Armstrong, Matthew, Ferguson, James W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Liver
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640386/ https://www.ncbi.nlm.nih.gov/pubmed/34917328 http://dx.doi.org/10.1136/flgastro-2020-101659

Ejemplares similares

Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

Epidemiology of Visceral Leishmaniasis in Algeria: An Update
por: Adel, Amel, et al.
Publicado: (2014)

Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection
por: Trehanpati, Nirupama, et al.
Publicado: (2012)

Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report
por: Riste, Michael, et al.
Publicado: (2021)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions
por: Hughes, Neill R, et al.
Publicado: (2013)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients
por: Anty, Rodolphe, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls
por: Hallsworth, Kate, et al.
Publicado: (2015)

Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents
por: Shiffman, Mitchell L, et al.
Publicado: (2016)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy
por: Dixon, Peter H, et al.
Publicado: (2014)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
por: Hudson, Mark, et al.
Publicado: (2017)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

Exercise therapy in primary biliary cirrhosis: the importance of moving while sitting on a surgical waiting list—a case study
por: Hallsworth, Kate, et al.
Publicado: (2016)

Alcohol care teams: where are we now?
por: Moriarty, Kieran John
Publicado: (2019)

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation
por: Millson, Charles, et al.
Publicado: (2020)

Adult liver transplantation: A UK clinical guideline - part 1: pre-operation
por: Millson, Charles, et al.
Publicado: (2020)

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community
por: Chalmers, Jane, et al.
Publicado: (2019)

Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)
por: Gordon, Victoria Mary, et al.
Publicado: (2021)

Widespread gaps in the quality of care for primary biliary cholangitis in UK
por: Sivakumar, Mathuri, et al.
Publicado: (2021)

Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
por: Lok, James, et al.
Publicado: (2020)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
por: Yeoman, Andrew, et al.
Publicado: (2020)

Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease
por: Neilson, Laura Jane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vqfe2tddpkabadj0p32ebdo734